These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10110117)
1. Rate reductions could affect patient outcomes, study says. Wagner L Mod Healthc; 1991 Apr; 21(16):12. PubMed ID: 10110117 [No Abstract] [Full Text] [Related]
2. Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule. Fed Regist; 1997 Aug; 62(158):43657-74. PubMed ID: 10169837 [TBL] [Abstract][Full Text] [Related]
3. Court invalidates parts of Medicare ESRD payment plan. Peterson RN; Pristave RJ Health Law Vigil; 1984 Sep; 7(19):7-12. PubMed ID: 10299657 [No Abstract] [Full Text] [Related]
4. The ESRD program: health policy microcosm. Wash Rep Med Health; 1982 Mar; ():1-4. PubMed ID: 10298456 [No Abstract] [Full Text] [Related]
5. The IOM report: an A+ for effort, but will it survive Washington's budget-cutting mood? Hull AR Nephrol News Issues; 1991 May; 5(5):28-9. PubMed ID: 1961288 [No Abstract] [Full Text] [Related]
6. The first DRG: lessons from the end stage renal disease program for the prospective payment system. Maxwell JH; Sapolsky HM Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335 [TBL] [Abstract][Full Text] [Related]
7. The Medicare end-stage renal disease program. A report from the Institute of Medicine. Levinsky NG; Rettig RA N Engl J Med; 1991 Apr; 324(16):1143-8. PubMed ID: 2008193 [No Abstract] [Full Text] [Related]
8. Medicare cuts: hopefully gone, but more likely, not forgotten (by Washington). Rubin R Nephrol News Issues; 1991 Apr; 5(4):16-7. PubMed ID: 1961278 [No Abstract] [Full Text] [Related]
9. Carrier payment delays biggest problem for ESRD facilities. Paganini E Nephrol News Issues; 1990 Apr; 4(4):39-42. PubMed ID: 2333120 [No Abstract] [Full Text] [Related]
11. Is it time again for patient selection criteria? Price CA Nephrol News Issues; 1992 Feb; 6(2):18-20. PubMed ID: 1290483 [No Abstract] [Full Text] [Related]
12. HCFA: failing to acknowledge the unique characteristics of the ESRD patient. Kanter A; Nidetz M Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135 [No Abstract] [Full Text] [Related]
13. Dialysis in Connecticut. Rettig RA Am J Kidney Dis; 1992 Jun; 19(6):614-6. PubMed ID: 1472189 [No Abstract] [Full Text] [Related]
15. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO? Besarab A; McCrea JB ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674 [No Abstract] [Full Text] [Related]
16. If daily dialysis is the answer, what is the question? Rettig RA Am J Kidney Dis; 2001 Apr; 37(4):862-5. PubMed ID: 11273889 [No Abstract] [Full Text] [Related]
17. Health policy report. Funding the End-Stage Renal-Disease Program. Iglehart JK N Engl J Med; 1982 Feb; 306(8):492-6. PubMed ID: 7035954 [No Abstract] [Full Text] [Related]
18. Home vs. in-center dialysis: reassessing the burdens. Schatell D Nephrol Nurs J; 2005; 32(3):347. PubMed ID: 16035476 [No Abstract] [Full Text] [Related]
19. Can we regulate the quality of care?: the case of dialysis in Connecticut. Brown E; Smith JD; Sindelar J Am J Kidney Dis; 1992 Jun; 19(6):609-13. PubMed ID: 1595713 [No Abstract] [Full Text] [Related]
20. ESRD centers deserve a level playing field.. Nidetz M Nephrol News Issues; 1989 Nov; 3(11):22-4. PubMed ID: 2594107 [No Abstract] [Full Text] [Related] [Next] [New Search]